Stifel Financial Corp Invests $43,000 in Inhibikase Therapeutics, Inc. (NYSE:IKT)
Stifel Financial Corp bought a new position in Inhibikase Therapeutics, Inc. (NYSE:IKT – Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm bought 13,129 shares of the company’s stock, valued at approximately $43,000. Several other hedge funds also recently made […]
Stifel Financial Corp bought a new position in Inhibikase Therapeutics, Inc. (NYSE:IKT – Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm bought 13,129 shares of the company’s stock, valued at approximately $43,000. Several other hedge funds also recently made […]
